Monoclonal Antibodies: Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product

Steven Shire

Published by Woodhead Publishing, 2015
ISBN 10: 0081002963 / ISBN 13: 9780081002964
Used / Hardcover / Quantity Available: 0
From Books Express (Kittery, ME, U.S.A.)
Available From More Booksellers
View all  copies of this book

About the Book

We're sorry; this specific copy is no longer available. AbeBooks has millions of books. We've listed similar copies below.

Description:

Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. May not contain Access Codes or Supplements. May be ex-library. Shipping & Handling by region. Buy with confidence, excellent customer service!. Bookseller Inventory # 0081002963

About this title:

Synopsis:

Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophysical methods combined with genetic engineering is used to understand the solution properties of the formulation. The latter has become very important since many indications such as arthritis and asthma require the development of formulations for subcutaneous delivery (SC). The development of formulations for IV delivery is also important and comes with a different set of challenges. The challenges and strategies that can overcome these limitations are discussed in this book, starting with an introduction to these issues, followed by chapters detailing strategies to deal with them. Subsequent chapters explore the processing and storage of mAbs, development of delivery device technologies and conclude with a chapter on the future of mAbs in therapeutic remedies.

  • Discusses the challenges to develop MAbs for intravenous (IV) and subcutaneous delivery (SC)
  • Presents strategies to meet the challenges in development of MAbs for SC and IV administration
  • Discusses the use of biophysical analytical tools coupled with MAb engineering to understand what governs MAb properties at high concentration

About the Author: Steven J. Shire is currently consulting and serving as an adjunct faculty member of the USC School of Pharmacy and University of Connecticut School of Pharmaceutical Sciences. He was at Genentech for 32 years where the majority of his career was in the pharmaceutical development department. He retired in June 2013 as Staff Scientist in the Late Stage Pharmaceutical Development Department. He has been responsible for directing research and development of formulations for a variety of recombinant human proteins including Pulmozyme® and Xolair®. Dr. Shire has served as the chair of the American Association of Pharmaceutical Scientists (AAPS) Biotechnology Section, and was elected as a Fellow of AAPS in 1998 and member at large to the AAPS Executive Council in 2001. He has published over 80 reviews and papers dealing with various aspects of formulation and pharmaceutical development of therapeutic proteins.

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Monoclonal Antibodies: Meeting the ...
Publisher: Woodhead Publishing
Publication Date: 2015
Binding: Hardcover
Book Condition: Good
Edition: 1.

Top Search Results from the AbeBooks Marketplace

1.

Steven Shire
Published by Woodhead Publishing Ltd 2015-04-30 (2015)
ISBN 10: 0081002963 ISBN 13: 9780081002964
New Hardcover Quantity Available: 20
Seller:
Chiron Media
(Wallingford, United Kingdom)

Book Description Woodhead Publishing Ltd 2015-04-30, 2015. Hardcover. Condition: New. Seller Inventory # 6666-ELS-9780081002964

More information about this seller | Contact this seller

Buy New
US$ 147.71
Convert currency

Add to Basket

Shipping: US$ 17.49
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Steven Shire
Published by ELSEVIER SCIENCE & TECHNOLOGY, United Kingdom (2015)
ISBN 10: 0081002963 ISBN 13: 9780081002964
New Hardcover Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)

Book Description ELSEVIER SCIENCE & TECHNOLOGY, United Kingdom, 2015. Hardback. Condition: New. Language: English. Brand new Book. Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophysical methods combined with genetic engineering is used to understand the solution properties of the formulation. The latter has become very important since many indications such as arthritis and asthma require the development of formulations for subcutaneous delivery (SC). The development of formulations for IV delivery is also important and comes with a different set of challenges. The challenges and strategies that can overcome these limitations are discussed in this book, starting with an introduction to these issues, followed by chapters detailing strategies to deal with them. Subsequent chapters explore the processing and storage of mAbs, development of delivery device technologies and conclude with a chapter on the future of mAbs in therapeutic remedies. Seller Inventory # EOD9780081002964

More information about this seller | Contact this seller

Buy New
US$ 150.83
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Shire, Steven
ISBN 10: 0081002963 ISBN 13: 9780081002964
New Quantity Available: 3
Seller:
GreatBookPricesUK
(Castle Donington, DERBY, United Kingdom)

Book Description Condition: New. Seller Inventory # 23066440-n

More information about this seller | Contact this seller

Buy New
US$ 156.32
Convert currency

Add to Basket

Shipping: US$ 18.28
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

Shire, Steven
ISBN 10: 0081002963 ISBN 13: 9780081002964
Used Quantity Available: 3
Seller:
GreatBookPricesUK
(Castle Donington, DERBY, United Kingdom)

Book Description Condition: As New. Unread book in perfect condition. Seller Inventory # 23066440

More information about this seller | Contact this seller

Buy Used
US$ 156.32
Convert currency

Add to Basket

Shipping: US$ 18.28
From United Kingdom to U.S.A.
Destination, rates & speeds

5.

Steven Shire
Published by ELSEVIER SCIENCE & TECHNOLOGY, United Kingdom (2015)
ISBN 10: 0081002963 ISBN 13: 9780081002964
New Hardcover Quantity Available: 1
Seller:
Book Depository International
(London, United Kingdom)

Book Description ELSEVIER SCIENCE & TECHNOLOGY, United Kingdom, 2015. Hardback. Condition: New. Language: English. Brand new Book. Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophysical methods combined with genetic engineering is used to understand the solution properties of the formulation. The latter has become very important since many indications such as arthritis and asthma require the development of formulations for subcutaneous delivery (SC). The development of formulations for IV delivery is also important and comes with a different set of challenges. The challenges and strategies that can overcome these limitations are discussed in this book, starting with an introduction to these issues, followed by chapters detailing strategies to deal with them. Subsequent chapters explore the processing and storage of mAbs, development of delivery device technologies and conclude with a chapter on the future of mAbs in therapeutic remedies. Seller Inventory # LIB9780081002964

More information about this seller | Contact this seller

Buy New
US$ 159.95
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

6.

Shire, Steven
ISBN 10: 0081002963 ISBN 13: 9780081002964
New Quantity Available: 3
Seller:
GreatBookPrices
(Columbia, MD, U.S.A.)

Book Description Condition: New. Seller Inventory # 23066440-n

More information about this seller | Contact this seller

Buy New
US$ 157.32
Convert currency

Add to Basket

Shipping: US$ 2.64
Within U.S.A.
Destination, rates & speeds

7.

Shire, Steven
ISBN 10: 0081002963 ISBN 13: 9780081002964
Used Quantity Available: 3
Seller:
GreatBookPrices
(Columbia, MD, U.S.A.)

Book Description Condition: As New. Unread book in perfect condition. Seller Inventory # 23066440

More information about this seller | Contact this seller

Buy Used
US$ 157.32
Convert currency

Add to Basket

Shipping: US$ 2.64
Within U.S.A.
Destination, rates & speeds

8.

Steven Shire
Published by ELSEVIER SCIENCE & TECHNOLOGY, United Kingdom (2015)
ISBN 10: 0081002963 ISBN 13: 9780081002964
New Hardcover Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)

Book Description ELSEVIER SCIENCE & TECHNOLOGY, United Kingdom, 2015. Hardback. Condition: New. Language: English. Brand new Book. Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophysical methods combined with genetic engineering is used to understand the solution properties of the formulation. The latter has become very important since many indications such as arthritis and asthma require the development of formulations for subcutaneous delivery (SC). The development of formulations for IV delivery is also important and comes with a different set of challenges. The challenges and strategies that can overcome these limitations are discussed in this book, starting with an introduction to these issues, followed by chapters detailing strategies to deal with them. Subsequent chapters explore the processing and storage of mAbs, development of delivery device technologies and conclude with a chapter on the future of mAbs in therapeutic remedies. Seller Inventory # LIB9780081002964

More information about this seller | Contact this seller

Buy New
US$ 160.23
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

9.

Steven Shire
Published by Woodhead Publishing Ltd 2015-04-30 (2015)
ISBN 10: 0081002963 ISBN 13: 9780081002964
New Hardcover Quantity Available: 3
Seller:
Chiron Media
(Wallingford, United Kingdom)

Book Description Woodhead Publishing Ltd 2015-04-30, 2015. Hardcover. Condition: New. Seller Inventory # 6666-LBR-9780081002964

More information about this seller | Contact this seller

Buy New
US$ 178.62
Convert currency

Add to Basket

Shipping: US$ 17.49
From United Kingdom to U.S.A.
Destination, rates & speeds

10.

SHIRE , STEVEN
Published by Woodhead Publishing (2015)
ISBN 10: 0081002963 ISBN 13: 9780081002964
New Hardcover Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)

Book Description Woodhead Publishing, 2015. Hardback. Condition: NEW. 9780081002964 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Seller Inventory # HTANDREE0890025

More information about this seller | Contact this seller

Buy New
US$ 181.99
Convert currency

Add to Basket

Shipping: US$ 18.28
From United Kingdom to U.S.A.
Destination, rates & speeds

There are 10 more copies of this book

View all search results for this book